Placenta
Volume 29 , Pages 169-177 , October 2008

Infertility as a Cancer Risk Factor – A Review

,Accepted 8 August 2008.

References 

  1. Brinton LA, Melton LJ, Malkasian GD, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol. 1989;129:712–722
  2. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of infertility drugs with in-vitro fertilization. Lancet. 1999;354:1586–1590
  3. Potashnik G, lerner-geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril. 1999;71:853–859
  4. Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovivi J, et al. Cancer incidence in a color of infertile women. Am J Epidemiol. 1998;147:1038–1042
  5. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie J, et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril. 2004;82:405–414
  6. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994;331:771–776
  7. Harlow BL, Weiss NS, Roth GS, Chu J, Daling JR. Case–control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. Cancer Res. 1988;48:5849–5852
  8. Tworoger SS, Fairfield KM, Colditz GA, Rosner BA, Hankinson SE. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol. 2007;166:894–901
  9. Jensen A, Sharif H, Jorgen HO, Kruger Kjaer S. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women. Am J Epidemiol. 2007;16(7):1400–1407
  10. Whittemore A, Harris R, Itnyre J. The collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol. 1992;135:1184–1203
  11. Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin N, Mosgaard BJ, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case–control studies. Am J Epidemiol. 2002;155:217–224
  12. Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG. A case–control study of ovarian cancer in relation to infertility and the use of ovulation induction drugs. Am J Epidemiol. 2004;160:1070–1078
  13. Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol. 1996;88:554–559
  14. Ron E, Lunenfeld B, Menczer J, Blumemstein T, katz L, Oelsner G, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol. 1987;125:780–790
  15. Melin A, Sparen P, Bergquist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod. 2007;22:3021–3026
  16. Brinton LA, Gridley G, Person I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997;176:572–579
  17. Berglund AS, Sparen O, Bergqvist A. Endometriosis and the risk of ovarian cancer. Abstract of the 19th Annual Meeting of ESHRE, Madrid, Hum Reprod, Abstract Book; 2003.
  18. Vercellini P, Parazzini F, Bolis G, Carinelli S, Dindelli M, Vendola N, et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol. 1993;169:181–182
  19. Ogawa S, Kuku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K, et al. Ovarian endometriosis associated with ovarian carcinoma: a clinic-pathological and immunohistochemical study. Gynecol Oncol. 2000;77:298–304
  20. Oral E, Ilvan S, Tustas E, Korbeyli B, Bese T, Demirkiran F, et al. Prevalence of endometriosis in epithelial ovary tumors. Eur J Obstet Gynecol Reprod Biol. 2003;109:97–101
  21. Garland M, hunter DJ, Coldhits GA, Manson JE, Stampfer MJ, Spiegelman D, et al. Menstrual cycle characteristics and history of ovulation infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol. 1998;147:636–642
  22. Anderson KE, Sellers TA, Chen P-L, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in large prospective study of women in IOWA. Cancer. 1997;79:494–499
  23. Terry KL, Willet WC, Rich-Edwards JW, et al. A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med. 2006;166:2484–2489
  24. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol. 1991;134:818–824
  25. Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol. 1993;22:1000–1009
  26. Weiss HA, Brinton LA, Potishman NA, Brogan D, Coates RJ, Gammon MD, et al. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol. 1999;28:816–823
  27. Ness RB, Modugno F. Endometriosis as a model for inflammation–hormone interactions in ovarian and breast cancer. Eur J Cancer. 2006;42:691–703
  28. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47
  29. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20:235–244
  30. Speert H. Carcinoma of the endometrium in young women. Surg Gynecol Obstet. 1949;88:332–336
  31. Jackson RL, Docherty MB. The Stein-Leventhal syndrome: analysis of 43 cases with special references to association with endometrial carcinoma. Am J Obstet Gynecol. 1957;73:161–173
  32. Hardiman P, Pillary OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet. 2003;361:1810–1812
  33. Peirpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol. 1998;51:581–586
  34. Jafari K, Javaheri G, Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal Syndrome. Obstet Gynecol. 1978;51:97–100
  35. Pillay OC, Wong Te Fong LF, Crow JC, Benjiamin E, Mould T, Atiomo W, et al. The association between polycystic ovaries and endometrial cancer. Human Reprod. 2006;21:924–929
  36. Rossing M, Daling J, Weiss N, Moore D, Self S. In situ and invasive cervical carcinoma in a cohort of infertile women. Fertil Steril. 1996;65:19–22
  37. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet. 1995;346:995–1000
  38. Rossing M, Daling J, Weiss N, Moore D, Self S. Risk of cutaneous melanoma in a cohort of infertile women. Melanoma Res. 1995;5:123–127
  39. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Althiuus MD, Mabie JE, et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology. 2005;11:111–117
  40. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case–control study. Br J Cancer. 1989;60:592–598
  41. Fathalla MF. Incessant ovulation – a factor in ovarian neoplasia?. Lancet. 1971;2:163
  42. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90:1774–1786
  43. Cook LS, Kamb ML, Weiss NS. Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol. 1997;145:459–465
  44. Paulson RJ. Fertility drugs and ovarian epithelial cancer: the endometriosis hypothesis. J Assist Reprod Genet. 1997;14:228–230
  45. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol. 2004 Jun;103(6):1194–1203
  46. Klip H, Burger CW, Leeuwen Van, the Omega Project Group . Risk of hormone-related cancers after ovarian stimulation for in-vitro fertilization in a cohort of 25,152 women. In:  Klip H editors. Long-term health effects of subfertility treatment. the Netherlands: PrintPartners Ipskamp B.V. Enschede; 2002;p. 55–82
  47. Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case–control study of ovarian cancer in Shanghai. Cancer Res. 1989 July 1;49(13):3670–3674
  48. Franceschi S, La Vecchia C, Negri E, Guarneri S, Montella M, Conti E, et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod. 1994 Sep;9(9):1673–1675
  49. Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod. 1997 Oct;12(10):2159–2161
  50. Miannay E, Boutemy JJ, Leroy-Billiard M, Gasnault JP, Leroy JL. The possible endometrial risk of ovarian stimulation. Apropos of 3 cases. J Gynecol Obstet Biol Reprod (Paris). 1994;23(1):35–38
  51. Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, et al. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol. 2005 Apr 1;161(7):607–615
  52. Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod. 2002;17:2209–2213
  53. Lerner-Geva L, Geva E, Lessing J, Chetrit A, Modan B, Amit A. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer. 2003;13:23–27
  54. Braga C, Negri E, La Vecchia C, Parazzini F, Dal Masso L, Franceschi S. Fertility treatment and risk of breast cancer. Hum Reprod. 1996;11:300–303
  55. Ricci E, Parazzini F, Negri E, Marsico S, La Vecchia C. Fertility drugs and the risk of breast cancer. Hum Reprod. 1999;14:1653–1655
  56. Weiss HA, Troisi R, Rossing MA, Brogan D, Coates RJ, Gammon MD, et al. Fertility problems and breast cancer risk in young women: a case–control study in the United States. Cancer Causes Control. 1998;9:331–339
  57. Burkman RT, Tang MT, Malone KE, Marchbanks PA, McDonald JA, Folger SG, et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril. 2003 Apr;79(4):844–851
  58. Gauthier E, Paoletti X, Clavel-Chapelon F, E3N group . Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod. 2004 Oct;19(10):2216–2221
  59. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of breast cancer in a cohort in infertile women. Gynecol Oncol. 1996 Jan;60(1):3–7
  60. Terry KL, Willett WC, Rich-Edwards JW, Michels KB. Clomiphene citrate use and reduced incidence of premenopausal breast cancer. Am J Epidemiol. 2004;159(Suppl. 66):2615
  61. Lerner-Geva L, Keinan-Boker L, Blumstein T, Boyko V, Olmar L, Mashiach S, et al. Infertility, ovulation induction treatments and the incidence of breast cancer – a historical prospective cohort of Israeli women. Breast Cancer Res Treat. 2006 Nov;100(2):201–212[Epub 2006 May 10]
  62. Young P, Purdie D, Jackman L, Molloy D, Green A. A study of infertility treatment and melanoma. Melanoma Res. 2001;11:535–541
  63. Althuis MD, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):668–674
  64. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control. 1990;1:223–234
  65. La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, et al. A pooled analysis of case control studies of thyroid cancer III, oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control. 1999;10:157–166
  66. Hannibal CG, Jensen A, Sharif H, Kjaer SK. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod. 2008 Feb;23(2):451–456

PII: S0143-4004(08)00244-0

doi: 10.1016/j.placenta.2008.08.007

Placenta
Volume 29 , Pages 169-177 , October 2008

Article Tools

* Image Usage & Resolution